Aspirin cardiovascular use labeling should advise physician consultation -- McNeil.
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN LABEL WITH PHYSICIAN CONSULTATION INSTRUCTIONS FOR CARDIOVASCULAR USERS suggested by McNeil Consumer Products in April 14 comments to FDA. McNeil, the maker of Tylenol brand acetaminophen, says in the letter that "consumer labeling for aspirin should advise patients taking low-dose aspirin under their physician's care for cardiovascular indications to consult with their physician on appropriate analgesic or antipyretic use."